Are the anxious oblivious?
Anxious people have long been classified as "hypersensitive" they're thought to be more fearful and feel threatened more easily than their counterparts. But new research from Tel Aviv University shows that the anxious may not be hypersensitive at all in fact, they may not be sensitive enough.
As part of a study on how the brain processes fear in anxious and non-anxious individuals, Tahl Frenkel, a Ph.D. candidate in TAU's School of Psychological Sciences and the Adler Center for Research in Child Developmental and Psychopathology, working with her supervisor Prof. Yair Bar-Haim, measured brain activity as study participants were shown images designed to induce fear and anxiety. Using an EEG to measure electrical activity caused by the neuronal activity that represents deep processing of these stimuli, the researchers discovered that the anxious group was actually less stimulated by the images than the non-anxious group.
The results of the study were recently published in Biological Psychology.
Measuring fear in the subconscious
Surprisingly, anxious study participants weren't shown to be as physiologically sensitive to subtle changes in their environment as less fearful individuals, Frenkel explains. She theorizes that anxious people could have a deficit in their threat evaluation capabilities necessary for effective decision-making and fear regulation leading to an under-reaction to subtle threatening stimuli. Non-anxious individuals seem to have a subconscious "early warning system," allowing them to prepare for evolving threats. Essentially, anxious people are "surprised" by fearful stimuli that non-anxious individuals have already subconsciously noticed, analyzed, and evaluated.
To get a more accurate picture of both behavioral and neural reactions to fear-inducing stimuli, the researchers drew participants from a group of 240 undergraduate students at the university. Using the Speilberger's State-Trait Anxiety Inventory trait scale, they identified the 10 percent "most anxious" individuals and 10 percent "least anxious" individuals to participate in the final study.
In the first part of their study, the researchers measured behavioral responses to fear-inducing stimuli. A set of pictures, featuring a person looking progressively more fearful on a scale of 1-100, was shown to the participants. When shown the sequence of pictures, anxious people were quicker to respond to the fear in the subject's face. They identified a face as being "fearful" at a rating of only 32, while non-anxious people did not describe the same face as fearful until it reached a rating of 39.
But the EEG data tells a different story, Frenkel says. The researchers also measured the participants' brain waves by EEG while they were being shown the photographs and discovered that non-anxious individuals completed an in-depth processing of fear-inducing stimuli that informed their behavioral response, whereas anxious individuals did not.
Compensating for an "insensitive" brain
When confronted with a potential threat, Frenkel concluded, non-anxious people unconsciously notice subtle changes in the environment before they consciously recognize the threat. Lacking such preparation, anxious individuals often react more strongly, as the threat takes them more "by surprise."
"The EEG results tell us that what looks like hypersensitivity on a behavioral level is in fact the anxious person's attempt to compensate for a deficit in the sensitivity of their perception," she explains.
Provided by Tel Aviv University
- Depressed? Fearful? It might help to worry, too Apr 01, 2010 | not rated yet | 0
- Reading a face is tricky business Jul 31, 2007 | not rated yet | 0
- New study finds mums not to blame for anxious kids Mar 19, 2009 | not rated yet | 0
- Fear of anxiety linked to depression in above-average worriers Dec 01, 2009 | not rated yet | 0
- New study and treatment available for kids facing phobias Mar 30, 2011 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013 As an experiment, for the past few months I've been consuming at least one portion of Jell-O or unflavored Knox gelatin per day. I'm 64, in very...
Alcohol and acetaminophen
May 13, 2013 Edit: sorry for the typo in the title , can't edit I looked around on google quite a bit and it's very hard to find precise information on the...
Marie Curie's leukemia
May 13, 2013 Does anyone know what might be the cause of Marie Curie's cancer
- More from Physics Forums - Medical Sciences
More news stories
Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the ...
Psychology & Psychiatry May 19, 2013 | 4.8 / 5 (5) | 1 |
The latest makeover to a massive psychiatric tome honored by some, reviled by others and even called the "Bible" of mental disorders is being released Saturday with a host of new changes.
Psychology & Psychiatry May 18, 2013 | not rated yet | 1
(HealthDay)—Most Medicare beneficiaries treated in inpatient psychiatric facilities (IPFs) exhibit characteristics associated with hospital readmission, according to a report prepared for the National Association ...
Psychology & Psychiatry May 17, 2013 | not rated yet | 0
Skydivers show the same level of physical stress before every jump whether a first-timer or experienced jumper, say Northumbria researchers.
Psychology & Psychiatry May 17, 2013 | not rated yet | 0 |
Children of depressed parents pick up on their parents' sadness—whether mom or dad realizes their mood or not.
Psychology & Psychiatry May 17, 2013 | 4.5 / 5 (2) | 1 |
Touted for safety, ease and patient convenience, peripherally inserted central catheters have become many clinicians' go-to for IV delivery of antibiotics, nutrition, chemotherapy, and other medications.
4 minutes ago | not rated yet | 0
Scientists at Johns Hopkins have turned their view of osteoarthritis (OA) inside out. Literally. Instead of seeing the painful degenerative disease as a problem primarily of the cartilage that cushions joints, ...
13 hours ago | 4.8 / 5 (5) | 0 |
In their quest to learn more about the variability of cells between and within tissues, biomedical scientists have devised tools capable of simultaneously measuring dozens of characteristics of individual ...
13 hours ago | 5 / 5 (3) | 0 |
Researchers at the University of Wisconsin have identified a potential new risk factor for obstructive sleep apnea: asthma. Using data from the National Institutes of Health (Heart, Lung, and Blood Institute)-funded Wisconsin ...
12 hours ago | 5 / 5 (1) | 0 |
A new study looking at sleep-disordered breathing (SDB) and markers for Alzheimer's disease (AD) risk in cerebrospinal fluid (CSF) and neuroimaging adds to the growing body of research linking the two.
12 hours ago | 5 / 5 (2) | 0 |
The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.
17 hours ago | not rated yet | 0